| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Biomarin Pharmaceutical Inc.'s insiders have reduced their positions by a net 17,557 shares worth roughly $1.2M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 214.6K | $11.95M | - | |
| CFO | 123.3K | $6.86M | - | |
| VP | 84.1K | $4.68M | - | |
| VP | 61.0K | $3.40M | - | |
| Dir | 49.4K | $2.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 28, 2016 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 120,000 | $81.30 | $9,756,438.00 | -27.1% | |
| Oct 17, 2016 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 41,666 | $84.39 | $3,516,227.07 | -11.4% | |
| Oct 14, 2016 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 64,125 | $86.96 | $5,576,377.01 | -16.5% | |
| Sep 30, 2016 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 53,125 | $92.02 | $4,888,780.31 | -12.3% | |
| Sep 29, 2016 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 53,125 | $93.65 | $4,974,901.25 | -12.3% | |
| Sep 27, 2016 | Jeffrey Robert Ajer58 | EVP, Chief Commercial Officer | Sell | 18,467 | $95.61 | $1,765,648.34 | -30.9% | |
| Sep 16, 2016 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 137,368 | $95.34 | $13,096,960.72 | -26.6% | |
| Aug 26, 2016 | Henry J Fuchs | EVP, Chief Medical Officer | Sale+OE | 15,000 | $95.06 | $1,425,924.00 | -11.6% | |
| Aug 16, 2016 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 41,666 | $91.49 | $3,811,868.18 | -9.9% | |
| Aug 1, 2016 | Daniel K Spiegelman59 | EVP, Chief Financial Officer | Sell | 4,000 | $99.33 | $397,320.00 | -8.5% |